Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Current cancer therapies often lack specificity, harming healthy cells.
• Scorpion venom (SV) has a history of medicinal use, including anti-cancer properties.
• SV contains diverse bioactive molecules with pharmacological effects.

Purpose of the Study:

• To review recent advances in SV-derived peptides as anti-cancer agents.
• To explore the diagnostic and therapeutic potential of these peptides in various cancers.
• To highlight the need for well-characterized SV peptides for adjuvant cancer therapy.

Main Methods:

• Literature review of scientific studies on scorpion venom and cancer.
• Analysis of pharmacological properties of SV-derived peptides.
• Focus on applications in glioma, breast, prostate, and colon cancers.

Main Results:

• SV-derived peptides exhibit potent anti-cancer activities.
• These peptides show potential for selective targeting of cancer cells.
• Evidence suggests efficacy in preclinical models of various cancers.

Conclusions:

• SV-derived peptides represent promising candidates for novel anti-cancer drugs.
• Further characterization is crucial for developing selective and effective adjuvant cancer therapies.
• These natural compounds could significantly improve patient survival and well-being.